Stay updated on Bepirovirsen in Chronic Hepatitis B Clinical Trial
Sign up to get notified when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.

Latest updates to the Bepirovirsen in Chronic Hepatitis B Clinical Trial page
- CheckyesterdayChange DetectedRecruitment status updated from Active, not recruiting to Completed. New Chinese sites were added with updated postal codes Hangzhou 310022, Liuzhou 545006, and Shenzhen 518112, while outdated site entries were removed.SummaryDifference0.3%

- Check9 days agoChange DetectedA new trial site has been added in Liuzhou, China, and Liuchow, China has been removed from the Locations list.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision/version is updated from **v3.5.2** to **v3.5.3**, indicating a system or site software update rather than any change to the study information.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the study locations, with Padova added and Padua removed.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study location entry was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

Stay in the know with updates to Bepirovirsen in Chronic Hepatitis B Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bepirovirsen in Chronic Hepatitis B Clinical Trial page.